The case for global gender-neutral HPV vaccination
Dr Robert Lown presents data from a recent study during a press conference at the 2013 ASH Annual Meeting on access to transplant for ethnic minority patients.
Previous studies have shown that minorities are poorly represented in international donor panels and therefore minority patients are often unable to find a suitable donor. While the number of registered donors has increased significantly in recent years and the use of cord blood and haploidentical transplants as treatment solutions for minority patients has expanded, the impact of these strategies remains largely unclear.
The case for global gender-neutral HPV vaccination
Boosting HPV vaccination in India: A call to action
Legislation – a powerful tool for promoting massive changes
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tackling breast cancer screening in conservative communities
Addressing the rise of multiple myeloma in Rwanda
Synthetic biology and precision medicine in blood and gynaecological cancers
Multiple myeloma (A cancer arising from plasma cells)
Haemopathy burden in the National Cancer Center of Cambodia